EUVIMEDEUVIMED entdecken
Crossref

First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment

Eran Galili iD, Irit Lubitz, Avner Shemer, Nadav Astman, Keren Pevzner, Zeala Gazit, Oz Segal, Anna Lyakhovitsky, Shiraz Halevi, Sharon Baum, Aviv Barzilai, Sharon Amit

Mycoses · 2024

DOI: 10.1111/myc.13812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2024. Verfasst von Eran Galili und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel. Hauptthemen laut MEDLINE: Terbinafine, Antifungal Agents, Drug Resistance, Fungal, Tinea. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trichophyton indotineae , a newly defined species within the T. mentagrophytes / T. interdigitale complex, has emerged as an epidemiological concern worldwide. However, owing to the limitations of commonly applied fungal identification techniques, T. indotineae remains underreported. In addition, T. indotineae 's response to treatment has been described in only a few studies.

Objective

To investigate the prevalence, clinical characteristics and treatment outcomes of terbinafine‐resistant T. mentagrophytes / T. interdigitale complex infections, as well as to detect T. indotineae cases. Patients and Methods A retrospective cohort study was conducted on 22 patients with T. mentagrophytes / T. interdigitale complex infections between 2019 and 2023, using either culture or commercial polymerase chain reaction methods. Patient demographics, disease characteristics and treatment responses were recorded. Patients non‐responsive to oral terbinafine underwent further analyses, including DNA sequencing of the internal transcribed spacer region for accurate species identification and mutational analysis of the squalene epoxidase ( SQLE ) gene.

Results

The mean age of the patients was 49.7 years (±18.2), with 54.5% men. Terbinafine‐resistant T. mentagrophytes / T. interdigitale complex infections were reported in 46.2% of the cohort ( n = 6/13 patients; 9 lost to treatment response follow‐up), all of whom exhibited extensive dermatophytosis. Among the terbinafine‐resistant T. mentagrophytes / T. interdigitale isolates, all five isolates available for fungal analysis were identified as T. indotineae , harbouring SQLE single‐point mutations (Phe397Leu and Leu393Ser). Only three of the terbinafine‐resistant cases responded to oral itraconazole 200 mg/day, with two responding only to oral voriconazole and one to oral itraconazole 400 mg/day.

Conclusion

All cases of T. mentagrophytes / T. interdigitale assessed in this study were identified as T. indotineae , which exhibits SQLE gene mutations. This underscores the importance of integrating methods to detect T. indotineae in routine clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TerbinafineAntifungal AgentsDrug Resistance, FungalTineaHumansMaleRetrospective StudiesMiddle AgedFemaleAdultAgedIsraelArthrodermataceaeTreatment OutcomeSqualene MonooxygenaseTrichophytonMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Trichophyton indotineaeTrichophyton mentagrophytes/Trichophyton interdigitale complexantifungal treatmentdermatophytetinea corporistreatment efficacy

Substanzen

TerbinafineAntifungal AgentsSqualene Monooxygenase

Autor:innen und Institutionen

  • Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel.
  • Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Clinical Microbiology, Sheba Medical Center, Ramat-Gan, Israel.

ORCID-Profile: Eran Galili

Zitieren

APA

Galili, E., Lubitz, I., Shemer, A., Astman, N., Pevzner, K., Gazit, Z., Segal, O., Lyakhovitsky, A., Halevi, S., Baum, S., Barzilai, A., & Amit, S. (2024). First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment. Mycoses. https://doi.org/10.1111/myc.13812

Vancouver

Galili E, Lubitz I, Shemer A, Astman N, Pevzner K, Gazit Z, et al. First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment. Mycoses. 2024. doi:10.1111/myc.13812

BibTeX
@article{Galili2024,
  author = {Galili, Eran and Lubitz, Irit and Shemer, Avner and Astman, Nadav and Pevzner, Keren and Gazit, Zeala and Segal, Oz and Lyakhovitsky, Anna and Halevi, Shiraz and Baum, Sharon and Barzilai, Aviv and Amit, Sharon},
  title = {First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment},
  journal = {Mycoses},
  year = {2024},
  doi = {10.1111/myc.13812}
}
Kostenlos starten →